The Characteristics, Treatment Patterns and Prognosis of Chinese Male Breast Cancer: A Real-world Study

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

The goal of this observational study is to investigate the features in Chinese male breast cancer (MBC) patients. The main question it aims to answer is: * The characteristics, treatment patterns and prognosis of Chinese MBC patients. The clinicopathological characteristics, treatment information and follow-up data of participants will be extracted from a Chinese national database (Chinese Society of Clinical Oncology Breast Cancer database) and other involved Chinese centers. Researchers will investigate the features, survival associated factors and other relevant factors of this population.

Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Healthy Volunteers: f
View:

• Biological sex is male;

• Microscopically diagnosed as primary breast cancer.

Locations
Other Locations
China
First affiliated hospital of Sun Yat-sen university
RECRUITING
Guangzhou
Contact Information
Primary
Yuxuan Gao, MD
gaoyx9@mail2.sysu.edu.cn
+86 18142846375
Time Frame
Start Date: 2021-08-01
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 1200
Treatments
Chinese
About 1,200 Chinese male breast cancer cases are anticipated to collected retrospectively. The clinicopathological characteristics, treatment and survival information are retrospectively collected.
Related Therapeutic Areas
Sponsors
Collaborators: Hebei Medical University Fourth Hospital, Fujian Provincial Hospital, Jiangmen Central Hospital, Affiliated Sanming First Hospital of Fujian Medical University, Peking University First Hospital, Jieyang People's Hospital, Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, The Third Hospital of Nanchang City, Zhanjiang Central Hospital, Beijing Medical Award Foundation, National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Peking University Shenzhen Hospital, Beijing 302 Hospital, Guangdong Women and Children Hospital, Lianjiang Pepole's Hospital, Lianjiang, The Third Affiliated Hospital of Kunming Medical University, First Affiliated Hospital Xi'an Jiaotong University, Shantou Central Hospital, The Second Affiliated Hospital of Harbin Medical University, First People's Hospital of Foshan, The Affiliated Hospital of Qingdao University, First Hospital of China Medical University, The First Affiliated Hospital with Nanjing Medical University, The Affiliated Hospital Of Guizhou Medical University, Guangdong Provincial Hospital of Traditional Chinese Medicine, The Affiliated Cancer Hospital of Zhengzhou University, The Affiliated Cancer Hospital of Xinjiang Medical University, The Second Affiliated Hospital, Guangzhou Medical University, Sun Yat-sen University, Guangdong Provincial People's Hospital, The First Affiliated Hospital, Zhejiang University
Leads: First Affiliated Hospital, Sun Yat-Sen University

This content was sourced from clinicaltrials.gov

Similar Clinical Trials